Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

9
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
9
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

14
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
14
Myocarditis IV: Nursing Management01:22

Myocarditis IV: Nursing Management

13
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
13
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

8
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
8
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

12
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Haemodynamic predictors of early aortic growth in uncomplicated type B dissection: a cohort study.

Interdisciplinary cardiovascular and thoracic surgery·2026
Same author

Untreated mild-moderate mitral regurgitation after isolated aortic valve replacement for aortic stenosis.

Journal of cardiothoracic surgery·2026
Same author

Short- and Mid-Term Outcomes of Robotic Mitral Valve Repair for Degenerative Mitral Regurgitation in Octogenarians.

Circulation reports·2026
Same author

Incidence, Timing, and Determinants of Stroke After Mitral Repair in Patients Without Preoperative Atrial Fibrillation.

Circulation journal : official journal of the Japanese Circulation Society·2026
Same author

Zone 1 total arch replacement with frozen elephant trunk for type A dissection: early-to-mid-term outcomes.

Journal of cardiothoracic surgery·2026
Same author

Evaluation of segmentation accuracy and the improvement of time effectiveness using deep learning-based segmentation in <sup>177</sup>Lu-DOTATATE dosimetry.

EJNMMI physics·2026

Related Experiment Video

Updated: Jul 18, 2025

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
05:04

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

3.4K

Paradigm shift in myocarditis treatment.

Ulugbek Yakhshimurodov1, Kizuku Yamashita1, Takuji Kawamura1

  • 1Department of Cardiovascular Surgery, Graduate School of Medicine, Osaka University, Osaka, Japan.

Journal of Cardiology
|August 19, 2023
PubMed
Summary

Myocarditis can lead to sudden cardiac death and chronic heart conditions. Emerging cell-based therapies show promise in reducing inflammation and improving cardiac function in animal models.

Keywords:
Cell therapyDilated cardiomyopathyMacrophageMyocarditisStem cells

More Related Videos

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.7K
Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

12.0K

Related Experiment Videos

Last Updated: Jul 18, 2025

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter
05:04

In vitro Assessment of Cardiac Reprogramming by Measuring Cardiac Specific Calcium Flux with a GCaMP3 Reporter

Published on: February 22, 2022

3.4K
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model
14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.7K
Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix
09:11

Cell-based Therapy for Heart Failure in Rat: Double Thoracotomy for Myocardial Infarction and Epicardial Implantation of Cells and Biomatrix

Published on: September 22, 2014

12.0K

Area of Science:

  • Cardiology
  • Regenerative Medicine

Background:

  • Myocarditis is a significant cause of sudden cardiac death in young individuals and can lead to dilated cardiomyopathy.
  • Current treatments for myocarditis include supportive care and specific etiologic therapies like immunosuppression for certain autoimmune or drug-induced forms.
  • Traditional treatments have limitations, prompting research into novel therapeutic approaches.

Purpose of the Study:

  • To review the evolving landscape of myocarditis treatment.
  • To highlight the potential of regenerative medicine, specifically cell-based therapies, in managing myocarditis and its complications.

Main Methods:

  • Review of current therapeutic strategies for myocarditis.
  • Analysis of studies evaluating stem cell therapy for myocarditis in animal models.

Main Results:

  • Cell-based therapies demonstrated a reduction in inflammation and myocardial fibrosis in experimental models.
  • Stem cell treatments showed potential in preventing systolic dysfunction and adverse cardiac remodeling associated with myocarditis.

Conclusions:

  • Regenerative cell and tissue-based therapies represent a promising advancement in myocarditis treatment.
  • Further research into cell-based therapies may offer new avenues for managing acute myocarditis and its chronic sequelae.